A recent study suggests that individuals who stop using popular GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Published data in a major health publication shows that while overweight people frequently drop substantial amounts of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping.
"Users buying such treatments must be aware of the risk of rapid weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain suggests a reversion to starting mass in about 18 months.
Weighing Therapies
The analysis, which reviewed 37 of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers emphasize that individuals who shed pounds through dieting usually see a slower weight regain—perhaps 0.1 kg a month—after stopping.
Understanding the Quick Regain
Experts propose the mode of action of the jabs is key to understanding the heightened weight return.
The injections imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating a significant risk."
A Chronic Condition?
Health authorities advise the injections for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals contend that, given the significant potential of weight regain, the therapy should be considered life-long.
This view is supported by drug manufacturers, who state that the results "highlight the chronic character of obesity," comparing it to managing conditions like diabetes.
User Testimonies
Individuals who have discontinued the jabs describe a intense resurgence of appetite.
"It was like something that goes on and you become ravenous," described an individual.
This difficulty is compounded if individuals have not established lasting lifestyle or habit modifications during treatment.
Growing Interest
Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is higher among women than men.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a magic cure and long-term success relies on ongoing behavioural changes.
